Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.40 |
| ▸ | UBE2N | P61088 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11071970 | 0.90 | CYP2C19 (0.56) | CYP2C19SMN1; SMN2CYP2D6SRCPOLB | |
| Xenyhexenic Acid SCHEMBL5158399 | 0.90 | CYP2C19 (0.51) | CYP2C19SMN1; SMN2GRIK1GRIK2 | |
| Xenyhexenic Acid SCHEMBL2734602 | 0.90 | CYP2C19 (0.51) | CYP2C19SMN1; SMN2GRIK1GRIK2 | |
| SCHEMBL10886683 | 0.87 | CYP2C19 (0.47) | CYP2C19CYP2D6SRCPOLBLMNA | |
| SCHEMBL10886677 | 0.87 | CYP2C19 (0.47) | CYP2C19CYP2D6SRCPOLBLMNA | |
| SCHEMBL6751630 | 0.86 | CYP2C19 (0.47) | CYP2C19 | |
| SCHEMBL9577467 | 0.86 | CYP2C19 (0.46) | CYP2C19SMN1; SMN2CYP2D6SRCPOLB | |
| SCHEMBL9577472 | 0.86 | CYP2C19 (0.46) | CYP2C19SMN1; SMN2CYP2D6SRCPOLB | |
| SCHEMBL10886154 | 0.84 | CYP2C19 (0.45) | CYP2C19SMN1; SMN2POLBLMNAEPHX1 | |
| SCHEMBL10886147 | 0.84 | CYP2C19 (0.45) | CYP2C19SMN1; SMN2POLBLMNAEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2437718-B1 | PHENOL ESTER AS PERFUMING INGREDIENT | FIRMENICH & CIE (CH) | 2013-03-27 | — | — | EP | claimed |
| US-20120045408-A1 | PHENOL ESTER AS PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2012-02-23 | — | — | US | claimed |
| US-8648032-B2 | Phenol ester as perfuming ingredient | FIRMENICH SA (CH) | 2014-02-11 | — | — | US | disclosed |
| US-20120045408-A1 | PHENOL ESTER AS PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2012-02-23 | — | — | US | disclosed |
| WO-1995011880-A1 | SUBSTITUTED AMIDES AS TACHYKININ ANTAGONISTS | MERCK SHARP & DOHME LIMITED (GB) | 1995-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045408-A1 | PHENOL ESTER AS PERFUMING INGREDIENT | HPD, CYP2E1, CYP2B6 | CYP2C19 11/4885SMN1; SMN2 4818/4885CYP2D6 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.